康龙化成大跌超7% 拟折让8.5%配股净筹近13.2亿港元

Core Viewpoint - 康龙化成 (300759) announced a placement of approximately 58.44 million new H-shares, leading to a decline of over 7% in its stock price, indicating market reaction to the dilution of shares and the pricing of the placement [1] Group 1: Share Placement Details - The share placement represents about 3.19% of the company's expanded total issued shares and approximately 16.57% of the total issued H-shares [1] - The placement price is set at HKD 22.82 per share, which reflects an 8.5% discount compared to the closing price on January 14 [1] - The expected total gross proceeds from the placement are approximately HKD 1.334 billion, with net proceeds estimated at HKD 1.319 billion [1] Group 2: Use of Proceeds - Approximately 70% of the proceeds will be allocated for project construction to enhance laboratory service facilities, drug process development, and production capacity [1] - About 10% of the funds will be used to repay bank loans and other borrowings to optimize the capital structure [1] - The remaining 20% will be utilized to supplement working capital and for other general purposes [1]